Analogously, treatment with resveratrol (Buhrmann et al., 2019) dramatically repressed TNF-β-induced NF-κB activation and EMT-associated with the parameters expression including decreasing vimentin and Slug, elevating E-cadherin, consequently leading to inhibit invasion and migration of CRC cells (HCT116, RKO, and SW480). This evidence concerns the gene NFKB1 and colorectal carcinoma.